Testing effectiveness (Phase 2)Ended earlyNCT00435227
What this trial is testing
Evaluate a Single Intramuscular Dose of Motavizumab to Treat Children With Respiratory Syncytial Virus (RSV) Illness
Who this might be right for
Participants Less Than 12 Months of Age With RSV Illness
MedImmune LLC 12